Viveve Medical, which is commercializing a non-invasive medical system that reverses vaginal laxity, raised $14 million by offering 2.7 million shares at $5. The company, which was listed on the OTCQB under the symbol VIVMF, had expected to raise $12.5 million by offering 1.56 million shares at $8 per share. Viveve Medical plans to list on the Nasdaq under the symbol VIVE. Ladenburg Thalmann and Craig-Hallum Capital Group acted as lead managers on the deal.
